$24.99 $0.83/serving
View Profile 
COMPASS Pathways
Editorial profileEditorially reviewed by ShrooMap Editorial Team
★ 4.3 / 5
• 500 reviews COMPASS Pathways is trailblazing the path for FDA-approved psilocybin therapy. They're advancing a proprietary synthetic psilocybin for treatment-resistant depression, with completed Phase 3 trials and an active rolling submission to bring this innovative treatment to patients.
✓ FDA Breakthrough Therapy ✓ NASDAQ Listed
Brand profile accuracy
Use this page as a shopping starting point, not batch-level proof.
ShrooMap records product listings, reputation signals, deal notes, and public brand details. Brand pages are not proof of current stock, legal status, owner verification, or lot-matched COAs. Check the exact product label, seller page, and current lab documents before buying.
Listing signal
Products and retailers can change without notice.
Proof check
COA status only matters when it matches the SKU and lot.
Correction loop
Send stale products, wrong URLs, or outdated claims to the queue.
1
Products
2016
Founded
About COMPASS Pathways
COMPASS Pathways (NASDAQ: CMPS) is the largest psychedelic medicine company in the world, developing COMP360 — a proprietary synthetic psilocybin formulation for treatment-resistant depression. With Phase 3 clinical trials completed and an FDA rolling submission underway as of early 2026, COMPASS represents the most advanced effort to bring psilocybin therapy through the pharmaceutical regulatory pathway. The company has also developed a proprietary therapy protocol and trained hundreds of therapists.
Founded By
George Goldsmith, Ekaterina Malievskaia
Special Features
- ✓ NASDAQ: CMPS publicly traded
- ✓ COMP360 psilocybin therapy
- ✓ Phase 3 clinical trials for depression
- ✓ FDA Breakthrough Therapy designation
- ✓ Proprietary therapy protocol
Key Mushrooms Used
Recognition & Media
Featured In
The New York Times Bloomberg BioPharma Dive STAT News
Quick Facts
- Country
- UK (London)
- Product Categories
- Pharmaceutical , Clinical psilocybin , Therapy
- Shipping
- Clinical Sites Only
Contact
COMPASS Pathways Products
All products from COMPASS Pathways reviewed on ShrooMap
Compare More Brands
Explore other top functional mushroom brands and find the perfect products for your wellness goals.
View All BrandsRelated Reading
Frequently Asked Questions
What should I check before buying COMPASS Pathways?
500 reviews and a 4.3/5 rating are available as reputation context; use them alongside labels and lab pages, not as batch proof. Profile notes: FDA Breakthrough Therapy, NASDAQ Listed. Confirm each item against the current package, official site, or underlying document before treating it as verified. Check the exact product name, serving details, ingredient panel, and whether a matching COA or lab result is available.
Where can I buy COMPASS Pathways products?
You can purchase COMPASS Pathways products directly from their official website at compasspathways.com. You can also check our headshop finder for local availability.
Does COMPASS Pathways do third-party lab testing?
No brand-specific testing policy is attached to this profile. Check the exact product, batch, and any current COA before relying on a testing claim.
What mushroom products does COMPASS Pathways sell?
COMPASS Pathways offers mushroom-extracts. Their products feature key mushrooms including Psilocybin Mushrooms. 1 COMPASS Pathways product pages are available for comparison.
How can I verify COMPASS Pathways details?
Start with the official website (compasspathways.com) and listed country (UK (London)). Then match product claims against the package, retailer page, and any available lab-result page. Media mentions include The New York Times, Bloomberg, BioPharma Dive.
Community Reviews
Share your experience and help others make informed decisions
Brand team?
Claim COMPASS Pathways and control the page.
Correct details for free, then upgrade for review responses, more photos, offers, product or menu highlights, and performance reporting.
Verified owner badge 12-photo gallery Review replies Deals + reporting